MedTrace Logo

Predicting Ovarian Response in Artificial Insemination With Low Stimulation

NCT01662180 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2012-12-13

No results posted yet for this study

Summary

This large prospective multi-center cohort study aims to identify patient's characteristics that significantly influence ovarian response to mild stimulation with a fixed dose of 75 IU recombinant FSH.

Conditions

  • Subfertility

Interventions

DRUG

Follicle Stimulating Hormone

All patients will receive a fixed 75 IU rec follicle stimulating hormone per day subcutaneous injection stimulation protocol starting from cycle day 3, 4 or 5. The intervention done in this study is conform normal stimulation protocol and is not the target of this study.

Sponsors & Collaborators

  • Merck Serono International SA

    collaborator INDUSTRY

  • Isala

    lead OTHER

Principal Investigators

  • Ben Cohlen, dr. · Isala

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-09-30
Completion
2015-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01662180 on ClinicalTrials.gov